MedTrace Logo

COVID19 Neurological Manifestation

NCT04496128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-08-16

No results posted yet for this study

Summary

This study is a prospective observational cohort study to document the prevalence and types of neurological manifestations among hospitalized patients with confirmed or suspected novel coronavirus infection (COVID-19).

Conditions

  • SARS-CoV 2
  • Neurologic Manifestations

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Sherry H Chou, MD, MSc · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-13
Primary Completion
2021-03-31
Completion
2021-05-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04496128 on ClinicalTrials.gov